A comparison of arsenate and vanadate as inhibitors or uncouplers of mitochondrial and glycolytic energy metabolism.
D000249:Adenosine Monophosphate; D000818:Animals; D001151:Arsenic / Q000494:pharmacology*; D001667:Binding, Competitive; D002417:Cattle; D004163:Diphosphoglyceric Acids; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors; D006019:Glycolysis / Q000187:drug effects*; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism; D009132:Muscles / Q000201:enzymology; D009198:Myiasis; D009206:Myocardium; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010103:Oxygen Isotopes; D010710:Phosphates / Q000494:pharmacology; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats; D014475:Uncoupling Agents / Q000494:pharmacology; D014639:Vanadium / Q000494:pharmacology*
D004163:Diphosphoglyceric Acids; D010103:Oxygen Isotopes; D010710:Phosphates; D014475:Uncoupling Agents; D014639:Vanadium; D000249:Adenosine Monophosphate; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D010770:Phosphotransferases; D001151:Arsenic